Frontlight ResearchEarly access
Trial site
Koseikai Takeda Hospital
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Stroke2 trials
- Phase
- Phase 34 trials
- Phase 1/21 trial
- Status
- Active, not recruiting4 trials
- Completed1 trial
- Lead sponsor
- Bayer1 trial
- Eisai Inc.1 trial
- Eli Lilly and Company1 trial
- Hoffmann-La Roche1 trial
- Janssen Research & Development, LLC1 trial
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026